Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels
Nehad M. Ayoub, Dalia R. Ibrahim, Amer E. Alkhalifa, Belal Al‐Husein
Topics & Concepts
CrizotinibFulvestrantAnaplastic lymphoma kinasePharmacologyEstrogen receptorCancer researchLapatinibTyrosine kinaseTyrosine-kinase inhibitorMedicineCancerBreast cancerInternal medicineReceptorLung cancerTrastuzumabMalignant pleural effusionLung Cancer Treatments and MutationsPancreatic and Hepatic Oncology ResearchCancer Research and Treatments